Clinical Trials in Michigan

Showing 8021-8040 of 12,290 trials

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

NCT02957461

This study is Part 1 of data collection from 18-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT03671083 (Part 2 with subject age range 13-25 years) for the final analyses of validation of the algorithms.

Brain Injuries, TraumaticConcussion, MildConcussion, Brain+2 more

BrainScope Company, Inc.420 participantsStarted Feb 2017

Fayetteville, Arkansas, United States • Storrs, Connecticut, United States • Tampa, Florida, United States +5 more locations

COMPLETED41 miles

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes

NCT02661633

This study (Part 2) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery. In addition, neuroimaging will be conducted at time of injury and following Return to Play (RTP).

Brain Injuries, TraumaticConcussion, BrainConcussion, Mild+2 more

BrainScope Company, Inc.177 participantsStarted Jan 2016

Fayetteville, Arkansas, United States • Bethesda, Maryland, United States • East Lansing, Michigan, United States +1 more locations

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

Objective Brain Function Assessment of mTBI/Concussion in High School Athletes

Find Trials by Condition in Michigan

The Chimerix CMX001 Registry

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

The PROOF Study: The PICC Related Obstruction Of Flow Study

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

ST266 Versus Standard Care In Treating Partial Thickness Burns

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Fenzian Asthma Multicenter Outcomes Study

Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma